Customizable Genomic Profiling of Cell-Free DNA for Oncology

Presented by
Alexandre Rouette
Clinical Specialist, CHU Sainte-Justine Children’s Hospital
James Flynn
Senior Staff Product Manager, Twist Bioscience
Maria Neofytou
Lecturer, University of Westminster

Covered in this Webinar
How assay design, sequencing strategy, and bioinformatics impact sensitivity
Methods for capturing and enriching low-frequency tumour signals
How design choices affect scalability and reproducibility in real-world settings

As liquid biopsy applications expand into earlier cancer detection and increasingly challenging clinical settings, assay performance has never been more critical. This session will explore how researchers and technology developers are improving assay sensitivity through advances in sequencing strategies, target enrichment and workflow optimisation. It will also examine how assay design decisions impact reproducibility, scalability and suitability for downstream use in translational research and clinical studies. 

Share your details to Watch the Webinar